International Clinical Trial: Fractional excretion of glucose in type 2 diabetes mellitus taking SGLT-2 inhibitors

Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (CTRI/2026/10/119257) titled 'Fractional excretion of glucose in type 2 diabetes mellitus taking SGLT-2 inhibitors' on Oct. 9.

Study Type: Interventional

Study Design: Non-randomized, Active Controlled Trial Method of generating randomization sequence:Other Method of allocation concealment:Other Blinding and masking:Open Label

Primary Sponsor: Anisha Modak

Condition: Health Condition 1: E119- Type 2 diabetes mellitus without complications

Intervention: Intervention1: Empagliflozin: Sodium Glucose Cotransporter 2 inhibitor, 25 mg, oral route, for 3 months Control Intervention1: Empagliflozin: Sodium Glucose Cotransporter 2 inhibi...